Wealth Effects’s DexCom DXCM Stock Holding History

Wealth Effects’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$269K	Hold	4,000	–	–	0.07%	203
2026 Q1	$251K	Hold	4,000	–	–	0.09%	185
2025 Q4	$265K	Hold	4,000	–	–	0.08%	166
2025 Q3	$269K	Hold	4,000	–	–	0.09%	173
2025 Q2	$349K	Hold	4,000	–	–	0.13%	127
2025 Q1	$273K	Buy	+4,000	New	+$326K	0.11%	151

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Wealth Effects's DXCM Position: Q2 2026 in Review

Wealth Effects held its DexCom (DXCM) position steady in Q2 2026 at 4,000 shares worth $269K. The position accounts for 0.07% of the portfolio, ranked #203.

Wealth Effects first reported a position in DXCM in Q1 2025 and has held it in 6 quarters since. The position peaked at $349K in Q2 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Wealth Effects held 4,000 shares of DexCom worth $269K as of Q2 2026.
Wealth Effects left its DexCom share count unchanged in Q2 2026.
DexCom made up 0.07% of Wealth Effects's portfolio in Q2 2026, its #203 holding.
Wealth Effects first reported a position in DexCom in Q1 2025 and has held it in 6 quarters since.
Wealth Effects's DexCom position peaked at $349K in Q2 2025.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Wealth Effects's 13F filing for Q2 2026, filed 6 Aug 2026.